540
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study

, , &
Pages 961-966 | Received 15 Dec 2015, Accepted 17 Feb 2016, Published online: 16 May 2016

References

  • Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–168.
  • Paula H, Asrani SK, Boetticher NC, et al. Alcoholic liver disease-related mortality in the US. Am J Gastroenterol. 2010;105:1782–1787.
  • Hsiang JC, Bai WW, Raos Z, et al. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand. Intern Med J. 2015;45:160–169.
  • Sandahl TD, Jepsen P, Thomsen KL, et al. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. J Hepatol. 2011;54:760.
  • Bang H-A, Kwon Y-H, Lee M-J, et al. Trends in the epidemiological aspects and mortality of alcoholic liver disease in Korea in the decade between 2000 and 2009. J Clin Med Res. 2015;7:91–96.
  • Jinjuvadia R, Liangpunsakul S. Translational research and evolving alcoholic hepatitis treatment consortium. Trends in alcoholic hepatitis-related hospitalizations, financial burden, and mortality in the United States. J Clin Gastroenterol. 2015;49:506–511.
  • Deleuran T, Vilstrup H, Becker U, et al. Epidemiology of alcoholic liver disease in Denmark 2006-2011: a population-based study. Alcohol Alcohol. 2015;50:352–357.
  • Sand J, Välikoski A, Nordback I. Alcohol consumption in the country and hospitalizations for acute alcohol pancreatitis and liver cirrhosis during a 20-year period. Alcohol. 2009;44:321–325.
  • Stokkeland K, Brandt L, Ekbom A, et al. Morbidity and mortality in liver diseases in Sweden 1969–2001 in relation to alcohol consumption. Scand J Gastroenterol. 2006;41:459–464.
  • Pärna K, Rahu K, Helakorpi S, et al. Alcohol consumption in Estonia and Finland: Finbalt survey 1994–2006. BMC Public Health. 2010;10:261.
  • Varis T, Virtanen S. Alcoholic beverage consumption 2013. National Institute of Health and Welfare, Helsinki, Finland: Official Statistics of Finland; 2014.
  • Hallberg J, Österberg E. Information on the nordic alcohol market 2014. Alco Inc., and National Institute for Health and Welfare, Helsinki, Finland: Nordic Studies on Alcohol and Drugs; 2014.
  • Nordic Alcohol Statistics. 2011. National Institute for Health and Welfare 2013; [cited 2016 Mar 1]. Available from: http://www.julkari.fi/bitstream/handle/10024/104396/Tr07_13.pdf?sequence=.
  • Jepsen P, Vilstrup H, Andersen PK, et al. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology. 2008;48:214–220.
  • Roberts SE. Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999. Gut. 2005;54:1615–1621.
  • Ratib S, Fleming KM, Crooks CJ, et al. 1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998–2009: a large population study. J Hepatol. 2014;60:282–289.
  • Fleming KM, Aithal GP, Card TR, et al. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int. 2011;32:79–84.
  • Sørensen HT, Thulstrup AM, Mellemkjar L, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol. 2003;56:88–93.
  • Ratib S, Fleming KM, Crooks CJ, et al. Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study. Am J Gastroenterol. 2015;110:1149–1158.
  • Orntoft NW, Sandahl TD, Jepsen P, et al. Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark. Clin Gastroenterol Hepatol. 2014;12:1739–1744.
  • Jepsen P, Ott P, Andersen PK, et al. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2009;51:1675–1682.
  • Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note no.10. End Results Evaluation Section, National Cancer Institute Bethesda, MD, 1959.
  • Hakulinen T, Seppä K, Lambert PC. Choosing the relative survival method for cancer survival estimation. Eur J Cancer. 2011;47:2202–2210.
  • Miettinen J, Rantanen M, Seppä K, et al. popEpi: functions for epidemiological analysis using Population Data. R package version 0.2.1, 2015; [cited 2015 Nov 3]. Available from: http://CRAN.R-project.org/package=popEpi.
  • Askgaard G, Grønbæk M, Kjær MS, et al. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J Hepatol. 2015;62:1061–1067.
  • Liang W, Chikritzhs T, Pascal R, et al. Mortality rate of alcoholic liver disease and risk of hospitalization for alcoholic liver cirrhosis, alcoholic hepatitis and alcoholic liver failure in Australia between 1993 and 2005. Int Med J. 2011;41:34–41.
  • Alvarez MA, Cirera I, Solà R, et al. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients. J Clin Gastroenterol. 2011;45:906–911.
  • Cuthbert JA, Arslanlar S, Yepuri J, et al. Predicting short-term mortality and long-term survival for hospitalized US patients with alcoholic hepatitis. Dig Dis Sci. 2014;59:1594–1602.
  • Liangpunsakul S. Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States. J Clin Gastroenterol. 2011;45:714–719.
  • Deleuran T, Grønbaek H, Vilstrup H, et al. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study. Aliment Pharmacol Ther. 2012;35:1336–1342.
  • Altamirano J, Miquel R, Katoonizadeh A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146:1231–1236.
  • O'Shea RS, Dasarathy S, McCullough AJ. Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology. 2009;51:307–328.
  • Mathurin P, O'Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255–260.
  • Thursz MR, Richardson P, Allison M, et al. Prednisolone or Pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619–1628.
  • Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12:231–242.
  • Bell H, Jahnsen J, Kittang E, et al. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol. 2004;39:858–863.
  • Potts JR, Goubet S, Heneghan MA, et al. Determinants of long-term outcome in severe alcoholic hepatitis. Aliment Pharmacol Ther. 2013;38:584–595.
  • Potts JR, Howard MR, Verma S. Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes. Eur J Gastroenterol Hepatol. 2013;25:659–664.
  • Kavli M, Strøm T, Carlsson M, et al. The outcome of critical illness in decompensated alcoholic liver cirrhosis. Acta Anaesthesiol Scand. 2012;56:987–994.
  • Fröhlich S, Murphy N, Kong T, et al. Alcoholic liver disease in the intensive care unit: outcomes and predictors of prognosis. J Crit Care. 2014;29:1131.e7–1131.e13.
  • Park JK, Lee CH, Kim IH, et al. Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease. J Korean Med Sci. 2015;30:598.
  • Corte Della C, Colombo M. Surveillance for hepatocellular carcinoma. Semin Oncol. 2012;39:384–398.
  • European Association for Study of Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599–564.
  • Schütte K, Bornschein J, Kahl S, et al. Delayed diagnosis of HCC with chronic alcoholic liver disease. Liver Cancer. 2012;1:257–266.
  • Trimble G, Zheng L, Mishra A, et al. Mortality associated with alcohol-related liver disease. Aliment Pharmacol Ther. 2013;38:596–602.
  • DiFranza JR. Alcoholism and smoking. J Stud Alcohol. 1990;51:130–135.
  • Grucza RA, Bierut LJ. Co-occurring risk factors for alcohol dependence and habitual smoking: update on findings from the Collaborative Study on the Genetics of Alcoholism. Alcohol Res Health. 2005;29:172–178.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.